Apixaban Impurity 29 | CAS 2413365-22-5 - Request Quote
Apixaban Impurity 29
| SZ CAT No: | SZ-A062040 |
| CAS No | 2413365-22-5 |
| Mol.F. | C20H23N3O3 |
| Mol.Wt. | 353.4 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Apixaban Impurity 29 is chemically 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)pyridin-2(1H)-one. Apixaban Impurity 29 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 29 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2413365-22-5
Purchase 2413365-22-5
Order 2413365-22-5
Enquire 2413365-22-5
price of 2413365-22-5
2413365-22-5 Supplier
2413365-22-5 Manufacturer
2413365-22-5 Exporter
buy high quality Apixaban Impurity 29
Purchase Apixaban Impurity 29
Apixaban Impurity 29 suppliers
Apixaban Impurity 29 manufacturers
Apixaban Impurity 29 price
Order Apixaban Impurity 29
Enquire Apixaban Impurity 29
Apixaban Impurity 29 cost
Apixaban Impurity 29 Supplier
Apixaban Impurity 29 Distributor
Apixaban Impurity 29 for Method Validation
Apixaban Reference Standard
Apixaban Impurity 29 for ANDA Filing
Apixaban Impurity 29 for Forced Degradation Studies
Apixaban Impurity 29 Identification Standards
Apixaban Impurity 29 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.